Skip to main content

Advertisement

Table 1 Evaluation of H1.3 immunohistochemistry [18]

From: Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma

Immunoreactivity
  H1.3 + cells
0 0–4%
1 5–24%
2 25–49%
3 50–100%
Intensity
0 negative
1 mild
2 intermediate
3 intense